Literature DB >> 15203405

Attitudes to long-term use of benzodiazepine hypnotics by older people in general practice: findings from interviews with service users and providers.

S Iliffe1, H V Curran, R Collins, S C Yuen Kee, S Fletcher, B Woods.   

Abstract

The aim of this study was to explore beliefs and attitudes about continuing or stopping benzodiazepine hypnotics amongst older patients using such medicines, and amongst their general practitioners. One hundred and ninety two patients aged 65 and over who were long-term users of benzodiazepine hypnotics were recruited from 25 general practices in inner city and suburban London, as were 83 practice staff. The practices had been recruited into a randomised controlled trial of benzodiazepine withdrawal in long-term users. Semi-structured interviews were conducted with patients recruited to the trial, and non-standardized (conversational) interviews with practice staff. Sixty percent of long-term benzodiazepine users had taken their hypnotic for more than 10 years, and one-third for more than 20 years. Beliefs in the efficacy of hypnotics, and self-report of insomnia despite their use, varied according to the willingness to attempt withdrawal. The majority of patients reported no warnings from professionals about adverse effects of using benzodiazepine hypnotics. Half had tried to stop at some time but most attempts had been short-lived. Patients and doctors had distinctly different views of the advantages, disadvantages and risks of stopping benzodiazepine hypnotic use. Both increased patient awareness of the problems of long-term benzodiazepine use and an evidence-based approach to withdrawal efforts in primary care are necessary to reduce the consumption of medication that has little real benefit.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15203405     DOI: 10.1080/13607860410001669778

Source DB:  PubMed          Journal:  Aging Ment Health        ISSN: 1360-7863            Impact factor:   3.658


  28 in total

Review 1.  Deprescribing Benzodiazepines in Older Patients: Impact of Interventions Targeting Physicians, Pharmacists, and Patients.

Authors:  Brendan J Ng; David G Le Couteur; Sarah N Hilmer
Journal:  Drugs Aging       Date:  2018-06       Impact factor: 3.923

2.  [Insomnia and increased use of sleep medication among seniors: problems and alternative treatment].

Authors:  Lynda Bélanger; Annie Vallières; Charles M Morin
Journal:  Can Fam Physician       Date:  2006-08       Impact factor: 3.275

3.  A benzodiazepine discontinuation programme does not increase the frequency of contacts with the family practice.

Authors:  Wim Gorgels; Richard Oude Voshaar; Audrey Mol; Eloy Van De Lisdonk; Jan Mulder; Henk Van Den Hoogen; Anton Van Balkom; Marinus Breteler; Frans Zitman
Journal:  Scand J Prim Health Care       Date:  2008       Impact factor: 2.581

4.  Psychotropic drug use among older people in general practice: discrepancies between opinion and practice.

Authors:  Andrea Lasserre; Nadia Younès; Thierry Blanchon; Inge Cantegreil-Kallen; Christine Passerieux; Guy Thomas; Christine Chan-Chee; Thomas Hanslik
Journal:  Br J Gen Pract       Date:  2010-04       Impact factor: 5.386

5.  Benzodiazepine use in Belgian nursing homes: a closer look into indications and dosages.

Authors:  Jolyce Bourgeois; Monique M Elseviers; Majda Azermai; Luc Van Bortel; Mirko Petrovic; Robert R Vander Stichele
Journal:  Eur J Clin Pharmacol       Date:  2011-12-22       Impact factor: 2.953

6.  Patients' and clinicians' experiences and perceptions of the primary care management of insomnia: qualitative study.

Authors:  Zowie Davy; Jo Middlemass; Aloysius N Siriwardena
Journal:  Health Expect       Date:  2013-08-19       Impact factor: 3.377

7.  Health care professionals' attitudes towards deprescribing in older patients with limited life expectancy: A systematic review.

Authors:  Carina Lundby; Trine Graabaek; Jesper Ryg; Jens Søndergaard; Anton Pottegård; Dorthe Susanne Nielsen
Journal:  Br J Clin Pharmacol       Date:  2019-02-27       Impact factor: 4.335

8.  Feasibility of discontinuing chronic benzodiazepine use in nursing home residents: a pilot study.

Authors:  Jolyce Bourgeois; Monique M Elseviers; Luc Van Bortel; Mirko Petrovic; Robert H Vander Stichele
Journal:  Eur J Clin Pharmacol       Date:  2014-08-08       Impact factor: 2.953

9.  Older primary care patients' willingness to consider discontinuation of chronic benzodiazepines.

Authors:  Joan M Cook; Tatyana Biyanova; Richard Thompson; James C Coyne
Journal:  Gen Hosp Psychiatry       Date:  2007 Sep-Oct       Impact factor: 3.238

Review 10.  Patient barriers to and enablers of deprescribing: a systematic review.

Authors:  Emily Reeve; Josephine To; Ivanka Hendrix; Sepehr Shakib; Michael S Roberts; Michael D Wiese
Journal:  Drugs Aging       Date:  2013-10       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.